Skip to main content
Top
Published in: BMC Cancer 1/2018

Open Access 01-12-2018 | Case report

Kaposi’s sarcoma of the conjunctiva and the eyelid leads to the diagnosis of human immunodeficiency virus infection – a case report

Authors: Filipe Sousa Neves, Joana Braga, João Cardoso da Costa, Joaquim Sequeira, Sandra Prazeres

Published in: BMC Cancer | Issue 1/2018

Login to get access

Abstract

Background

The purpose of this case report is to describe a conjunctiva and eyelid Kaposi’s sarcoma (KS) as the initial manifestation of acquired immunodeficiency syndrome (AIDS), which led to the diagnosis of HIV infection. There are only 3 reported cases of ocular KS as an initial manifestation of HIV infection.

Case presentation

A 32-year old white man presented to our department with a 1 month history of eye redness. The patient had an enlarged violet-coloured mass on the right superior eyelid which had evolved over the course of 1 week. There was also a mobile bulbar conjunctival lesion with a bright red colour, approximately 5 mm × 5 mm, in the superior temporal quadrant of his left eye. The lesions looked like a chalazion and a subconjunctival haemorrhage, respectivly. Presumed KS diagnosis was confirmed with HIV-1 positive testing and histopathology from tissue biopsy. The patient’s CD4 count was 23/mm3 and viral RNA load 427,000/ml. Further systemic evaluation showed a diffuse sarcoma.

Conclusion

This case report demonstrates the importance of recognizing the ocular manifestations of AIDS in establishing the correct diagnosis of KS and subsequently diagnosing occult HIV infection. Although ocular KS as the initial manifestation of HIV-AIDS is an extremely rare event, a proper diagnosis may contribute to prompt management with personal and social relevance.
Literature
1.
go back to reference Holland GN, Pepose JS, Pettit TH, Gottlieb MS, Yee RD, Foos RY. Acquired immunodeficiency syndrome: ophthalmic manifestations. Ophthalmology. 1983;90(8):859–73.CrossRefPubMed Holland GN, Pepose JS, Pettit TH, Gottlieb MS, Yee RD, Foos RY. Acquired immunodeficiency syndrome: ophthalmic manifestations. Ophthalmology. 1983;90(8):859–73.CrossRefPubMed
2.
go back to reference Rosenberg PR, Uliss AE, Friedland GH, Harris CA, Small CB, Klein RS. Acquired immunodeficiency syndrome: ophthalmic manifestations in ambulatory patients. Ophthalmology. 1983;90(8):874–8.CrossRefPubMed Rosenberg PR, Uliss AE, Friedland GH, Harris CA, Small CB, Klein RS. Acquired immunodeficiency syndrome: ophthalmic manifestations in ambulatory patients. Ophthalmology. 1983;90(8):874–8.CrossRefPubMed
5.
go back to reference Leder HA, Galor A, Peters GB, Kedhar SR, Dunn JP, Thorne JE. Resolution of conjunctival kaposi sarcoma after institution of highly active antiretroviral therapy alone. Br J Ophthalmol. 2008;92(1):151.CrossRefPubMed Leder HA, Galor A, Peters GB, Kedhar SR, Dunn JP, Thorne JE. Resolution of conjunctival kaposi sarcoma after institution of highly active antiretroviral therapy alone. Br J Ophthalmol. 2008;92(1):151.CrossRefPubMed
9.
go back to reference Schmid K, Wild T, Bolz M, Horvat R, Jurecka W, Zehetmayer M. Kaposi’s sarcoma of the conjunctiva leads to a diagnosis of acquired immunodeficiency syndrome. Acta Ophthalmol Scand. 2003;81(4):411–3.CrossRefPubMed Schmid K, Wild T, Bolz M, Horvat R, Jurecka W, Zehetmayer M. Kaposi’s sarcoma of the conjunctiva leads to a diagnosis of acquired immunodeficiency syndrome. Acta Ophthalmol Scand. 2003;81(4):411–3.CrossRefPubMed
10.
go back to reference Curtis TH, Durairaj VD. Conjunctival kaposi sarcoma as the initial presentation of human immunodeficiency virus infection. Ophthal Plast Reconstr Surg. 2005;21(4):314–5.CrossRefPubMed Curtis TH, Durairaj VD. Conjunctival kaposi sarcoma as the initial presentation of human immunodeficiency virus infection. Ophthal Plast Reconstr Surg. 2005;21(4):314–5.CrossRefPubMed
11.
go back to reference Mika K, Pogrzebielski A, Dyduch G, Romanowska-Dixon B. Kaposi sarcoma of the conjunctiva as the first manifestation of HIV infection. Am J Case Rep. 2010;11:64–6. Mika K, Pogrzebielski A, Dyduch G, Romanowska-Dixon B. Kaposi sarcoma of the conjunctiva as the first manifestation of HIV infection. Am J Case Rep. 2010;11:64–6.
12.
go back to reference Haye C, Dhermy P, Chic F, Schlienger P. Kaposi’s sarcoma of the eyelid as a manifestation of AIDS. Bull Soc Ophthalmol Fr. 1987;87(2):233–6. Haye C, Dhermy P, Chic F, Schlienger P. Kaposi’s sarcoma of the eyelid as a manifestation of AIDS. Bull Soc Ophthalmol Fr. 1987;87(2):233–6.
13.
go back to reference Soll DB, Redovan EG. Kaposi’s sarcoma of the eyelid as the initial manifestation of AIDS. Ophthal Plast Reconstr Surg. 1989;5(1):49–51.CrossRefPubMed Soll DB, Redovan EG. Kaposi’s sarcoma of the eyelid as the initial manifestation of AIDS. Ophthal Plast Reconstr Surg. 1989;5(1):49–51.CrossRefPubMed
14.
go back to reference Kurumetry UR, Lustbader JM. Kaposi’s sarcoma of the bulbar conjunctiva as an initial clinical manifestation of acquired immunodeficiency syndrome. Arch Ophthalmol. 1995;113(8):978.CrossRef Kurumetry UR, Lustbader JM. Kaposi’s sarcoma of the bulbar conjunctiva as an initial clinical manifestation of acquired immunodeficiency syndrome. Arch Ophthalmol. 1995;113(8):978.CrossRef
15.
go back to reference Teixeira AI, Neno M, Badura R, Borges-Costa J, Filipe PL. Kaposi sarcoma of the eyelid as initial manifestation of AIDS. Dermatol Online J. 2016;15(22):7. Teixeira AI, Neno M, Badura R, Borges-Costa J, Filipe PL. Kaposi sarcoma of the eyelid as initial manifestation of AIDS. Dermatol Online J. 2016;15(22):7.
Metadata
Title
Kaposi’s sarcoma of the conjunctiva and the eyelid leads to the diagnosis of human immunodeficiency virus infection – a case report
Authors
Filipe Sousa Neves
Joana Braga
João Cardoso da Costa
Joaquim Sequeira
Sandra Prazeres
Publication date
01-12-2018
Publisher
BioMed Central
Published in
BMC Cancer / Issue 1/2018
Electronic ISSN: 1471-2407
DOI
https://doi.org/10.1186/s12885-018-4611-3

Other articles of this Issue 1/2018

BMC Cancer 1/2018 Go to the issue
Webinar | 19-02-2024 | 17:30 (CET)

Keynote webinar | Spotlight on antibody–drug conjugates in cancer

Antibody–drug conjugates (ADCs) are novel agents that have shown promise across multiple tumor types. Explore the current landscape of ADCs in breast and lung cancer with our experts, and gain insights into the mechanism of action, key clinical trials data, existing challenges, and future directions.

Dr. Véronique Diéras
Prof. Fabrice Barlesi
Developed by: Springer Medicine